Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Department of Ophthalmology, Hadassah Medical Center, Jerusalem, 12000, POB, Israel.
Graefes Arch Clin Exp Ophthalmol. 2024 Oct;262(10):3385-3391. doi: 10.1007/s00417-024-06546-2. Epub 2024 Jun 14.
Bilateral pediatric cataract (BPC) is one of the most common causes of childhood visual impairment and blindness worldwide. A significant percentage of pediatric cataracts are caused by genetic alterations. We aim to characterize the set of genes and variants that cause BPC in the Israeli and Palestinian populations and to assess genotype-phenotype correlation.
Retrospective study in a multidisciplinary center for visual impairment, located in a tertiary medical center. Medical charts of families who underwent genetic counseling because of BPC in a family member were reviewed. Clinical characteristics and genetic tests results were obtained from medical records of affected subjects.
Twenty-two families (47 patients) underwent genetic counseling and completed genetic testing. Causative variants were identified in 18/22 (81.8%) of the families, including 3 novel variants. Genetic testing used included mainly panel for congenital cataracts and whole exome sequencing. Eleven families performed genetic testing with the intention of future pregnancy planning. Main causative genes identified were crystalline genes followed by transcription factor genes. BCOR gene variants were associated with persistent fetal vasculature (PFV) cataract in two of three families.
Combined molecular techniques are useful in identifying variants causing pediatric cataracts and showed a high detection rate in our population. BCOR gene variants might be associated with PFV type of cataracts. The study of pathogenic variants may aid in family planning and prevention of pediatric cataracts in future pregnancies. Additionally, in certain cases, it assists in diagnosing non-suspected syndromic types of pediatric cataracts.
双侧小儿白内障(Bilateral pediatric cataract,BPC)是全球儿童视力损害和失明的最常见原因之一。相当一部分小儿白内障是由遗传改变引起的。我们旨在描述导致以色列和巴勒斯坦人群 BPC 的基因和变体,并评估基因型-表型相关性。
位于三级医疗中心的一个视觉障碍多学科中心的回顾性研究。对因家庭成员中存在 BPC 而接受遗传咨询的家庭的医疗图表进行了回顾。从受影响受试者的病历中获得了临床特征和基因测试结果。
22 个家庭(47 名患者)接受了遗传咨询并完成了基因测试。在 22 个家庭中的 18 个(81.8%)中确定了致病变异,包括 3 个新变异。使用的基因测试主要包括先天性白内障基因检测和全外显子测序。11 个家庭进行了基因测试,目的是为未来的妊娠计划。主要鉴定出的致病基因是晶体基因,其次是转录因子基因。BCOR 基因变异与三分之二家族中的持续性胎儿血管(Persistent fetal vasculature,PFV)白内障有关。
联合分子技术可用于识别导致小儿白内障的变异,并在我们的人群中显示出较高的检测率。BCOR 基因变异可能与 PFV 型白内障有关。对致病性变异的研究可能有助于未来妊娠的家庭计划和预防小儿白内障。此外,在某些情况下,它有助于诊断非疑似综合征型小儿白内障。